Enzalutamide (CAS 915087-33-1): A Comprehensive Product Introduction
Enzalutamide, with the CAS number 915087-33-1, is a remarkable pharmaceutical compound that has gained significant attention in the medical and scientific communities. This article aims to provide a detailed and in – depth introduction to Enzalutamide, covering its properties, uses, applications in various fields, and preparation methods.
I. Product Overview
Enzalutamide is a non – steroidal anti – androgen drug. It is specifically designed to target and inhibit the androgen receptor (AR) signaling pathway, which plays a crucial role in the growth and survival of prostate cancer cells. The chemical formula of Enzalutamide is \(C_{21}H_{16}F_4N_4O_2\), and its molecular weight is approximately 432.37 g/mol. Its chemical structure consists of a complex arrangement of atoms that allows it to interact effectively with the androgen receptor.
Enzalutamide is a white to off – white powder. It is sparingly soluble in water, but soluble in organic solvents such as dimethyl sulfoxide (DMSO) and ethanol. These solubility properties are important for its formulation into various dosage forms for medical use.
II. Properties of Enzalutamide
A. Physical Properties
As mentioned earlier, Enzalutamide exists as a white to off – white powder. Its melting point is around 198 – 202°C. The compound has a relatively high purity when synthesized under proper conditions, usually reaching over 98%. Its density and refractive index are also characteristic physical properties that can be used for quality control and identification purposes.
B. Chemical Properties
Enzalutamide is chemically stable under normal storage conditions. However, it may be sensitive to strong acids, bases, and oxidizing agents. The presence of functional groups such as amide, aryl, and fluoro – substituted moieties in its structure contributes to its chemical reactivity. For example, the amide group can undergo hydrolysis under acidic or basic conditions, which needs to be considered during its storage and formulation.
III. Uses of Enzalutamide
A. Medical Use
The primary use of Enzalutamide is in the treatment of prostate cancer. It is indicated for the treatment of metastatic castration – resistant prostate cancer (mCRPC) in men. By binding to the androgen receptor, Enzalutamide blocks the binding of androgens such as testosterone and dihydrotestosterone, thereby preventing the activation of the AR signaling pathway. This leads to the inhibition of prostate cancer cell growth, proliferation, and survival.
Clinical trials have shown that Enzalutamide can significantly improve overall survival, delay disease progression, and reduce the risk of skeletal – related events in patients with mCRPC. It is usually administered orally in the form of capsules, with a recommended dosage of 160 mg once daily. The treatment regimen may be adjusted according to the patient’s condition and response to the drug.
B. Research Use
In addition to its medical use, Enzalutamide is also widely used in scientific research. It serves as a valuable tool for studying the androgen receptor signaling pathway and its role in various biological processes. Researchers can use Enzalutamide to investigate the molecular mechanisms of prostate cancer development, progression, and resistance. It can also be used to screen for new drugs that target the androgen receptor or related pathways.
IV. Applications in Various Fields
A. Pharmaceutical Industry
In the pharmaceutical industry, Enzalutamide is a key product for the treatment of prostate cancer. Pharmaceutical companies are involved in the large – scale production, formulation, and marketing of Enzalutamide – containing drugs. The development of new dosage forms, such as controlled – release formulations, is an area of ongoing research to improve the bioavailability and patient compliance of Enzalutamide.
B. Biotechnology
In the field of biotechnology, Enzalutamide is used in cell – based assays and animal models to study the effects of androgen receptor inhibition on cell growth, gene expression, and signaling pathways. It can also be used in the development of biomarker – based diagnostic tests for prostate cancer, as changes in the androgen receptor signaling pathway can be detected in biological samples from patients treated with Enzalutamide.
C. Academic Research
Academic researchers use Enzalutamide in a wide range of studies, including basic science research on the androgen receptor, translational research to develop new treatment strategies for prostate cancer, and clinical research to evaluate the long – term safety and efficacy of Enzalutamide in different patient populations. The data generated from these studies contribute to the advancement of knowledge in the field of oncology.
V. Preparation Methods of Enzalutamide
A. Chemical Synthesis
The synthesis of Enzalutamide typically involves a multi – step chemical process. One of the common synthetic routes starts with the preparation of key intermediates. For example, the reaction of an appropriate aryl halide with a substituted amine can form an intermediate with the desired aryl – amine linkage. Subsequent reactions, such as acylation, fluorination, and cyclization, are carried out to build the final structure of Enzalutamide.
The reaction conditions for each step need to be carefully optimized to ensure high yield and purity of the product. Solvents, catalysts, and reaction temperatures play important roles in the synthesis process. For instance, the use of appropriate catalysts can accelerate the reaction rate and improve the selectivity of the reaction.
B. Process Optimization
To improve the efficiency and cost – effectiveness of Enzalutamide synthesis, process optimization is essential. This includes the development of new synthetic routes, the use of green chemistry principles, and the improvement of reaction conditions. For example, the use of alternative solvents that are more environmentally friendly and the reduction of waste generation can make the synthesis process more sustainable.
VI. Safety and Handling
Enzalutamide should be handled with care. It is a pharmaceutical compound, and proper safety precautions should be taken during its production, storage, and use. Protective equipment such as gloves, goggles, and lab coats should be worn when handling Enzalutamide. It should be stored in a cool, dry place away from direct sunlight and sources of heat.
In case of accidental exposure, appropriate first – aid measures should be taken. If ingested, medical attention should be sought immediately. The disposal of Enzalutamide and its waste products should comply with relevant environmental and safety regulations.
VII. References
- Author, A., & Author, B. (Year). Title of the Article. Journal Name, Volume(Issue), Page – Page.
- Author, C., Author, D., & Author, E. (Year). Another Article Title. Another Journal, Volume(Issue), Page – Page.